T45-29075-12664
1 vaccination
1 coded response
3 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 201 / VA
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-21
Registered in v-safe
-
2021-05-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-05-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Fatigue or tiredness, NauseaAdult check-in
-
2021-05-23
Survey response — days 1–6 daily, dose 1MedDRA: Faeces discoloured — Feeling: Fair · Site: Pain · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Janssen/Johnson & Johnson |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Faeces discoloured | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release